1 Interactive introduction in Quality of life Assessment Jan J. v. Busschbach, Ph.D. Department of Medical Psychology and Psychotherapy, Erasmus MC

Slides:



Advertisements
Similar presentations
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Advertisements

Emma Frew Introduction to health economics, MSc HEHP, October 2012 Outcomes: part II.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
Scaling Session Measurement implies “assigning numbers to objects or events…” Distinguish two levels: we can assign numbers to the response levels for.
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 The QALYs debate  Prof. dr. Jan J.V. Busschbach, Ph.D.  Erasmus MC  Institute for Medical Psychology and Psychotherapy.
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Prof. dr. Jan van Busschbach Department of Medical Psychology & Psychotherapy Erasmus MC.
Utility Assessment HINF Medical Methodologies Session 4.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Quality of life Assessment introduction
QUALITY OF LIFE ASSESSMENT IN PEOPLE LIVING WITH HIV/AIDS Antonieta Medina Lara HIV/AIDS and STI Knowledge Programme Liverpool School of Tropical Medicine.
Quality of Life Assessment in Clinical Trials Adapted from Introduction to Clinical Trials Biostatistics.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Measuring the “Q” in QALYs for cost- effectiveness analysis: the EuroQol Group’s approach Valuing health outcomes for healthcare decision making using.
Overview of the EQ-5D Purpose and origins of the descriptive system.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
H EALTH R ELATED Q UALITY OF L IFE Fowad Khurshid PHCL
Rescuing Clinical Trial Data For Economic Evaluation
Measuring Health Outcomes
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
1 Reconciliation of Economic Arguments and Clinical Practice Monday November 4, 2002 ISPOR, Rotterdam Jan Busschbach PhD, –Department of Medical Psychology.
1 Patient values or values from the general public.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
1 QALY, Burden of Disease and Budget Impact  Jan J.V. Busschbach, Ph.D.  Erasmus MC, Rotterdam, The Netherlands  
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
CIA Annual Meeting Session 3203 Measuring Wellness: The Issues? Tom Brogan President June 28 th, 2005.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 Cost effectiveness as argument for reimbursement in prevention Jan J. v. Busschbach, Ph.D. Erasmus MC –Institute for Medical Psychology and Psychotherapy.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.
1 Scale recalibration effects in dementia patients and their proxies Sander Arons Dept. of Epidemiology, Biostatistics and HTA Radboud University Nijmegen.
Cost-Effectiveness of Psychotherapy for Personality Disorders Soeteman, Busschbach, Verheul.
Cost-effectiveness in the quest to convince the outside world Dr. Jan Busschbach De Viersprong Erasmus MC
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Scaling Session Measurement implies assigning numbers to objects or events. In our case, the numbers “weight” responses to questions, so that saying “Yes”
Cost-Effectiveness of Psychotherapy (for Personality Disorders) Prof. dr. Jan van Busschbach.
Values Lower Than Death Jan J. v. Busschbach, Ph.D. –Erasmus University Rotterdam institute for Medical Technology Assessment (iMTA) PO box DR.
How to weight cost effectiveness in appraisal NVTAG / CVZ course: The appraisal process, work in progress 22th of April 2009 Jan van Busschbach.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 Are values cultural determined…..  Many believe that QoL is cultural determined  One of the starting points of the EuroQol group.
© University of South Wales Royal College of Speech and Language Therapists Outcomes Conference and Hub Launch Belfast, May 1, 2014 Running a tight ship:
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 7: Cost-effectiveness analysis – Part.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?
1 VAS, SG, TTO and PTO An Interactive Introduction.
1 Utilization of Quality of Life Research in Decision-Making and Policy  Prof. Dr. Jan J.V. Busschbach  Erasmus MC, Rotterdam, The Netherlands  Section.
The burden of disease in patients with personality disorder indicated for psychotherapy: Arguments for necessity of care Djøra Soeteman, MSc
Global burden of diseases
Quality of Life Assessment
Prof. Dr. Jan J.V. Busschbach
Measurement Wu Gong, MS, MD
The valuation of disease-specific questionnaires for QALY analysis
PUBLIC HEALTH – INTRODUCTION HEALTH STATUS OF A POPULATION
Measuring outcomes Emma Frew October 2012.
Presentation transcript:

1 Interactive introduction in Quality of life Assessment Jan J. v. Busschbach, Ph.D. Department of Medical Psychology and Psychotherapy, Erasmus MC – Psychotherapeutic Centrum ‘De Viersprong’, Halsteren –

2 New cancer therapy SymptomsDrug XDrug Y Survival days Days sick of chemotherapy Days sick of disease TWiST

3 Time Without Symptoms of disease and subjective Toxic effects of treatment TWiST –Developed by Gelber (statistician) In search for a typical “cancer” problem –Often prolonged life but also a reductions in quality of life »At the beginning (side effects) »At the end –Only count the days without symptoms of disease and subjective toxic effects of the treatment

4 TWiST ignores differences in quality of life TWiST –Healthy = 1 –Sick (dead) = 0 There is more to life than sick/health –Make intermediate values –Q-TWiST »Quality of life adjusted adjusted TWiST How to scale quality of life? What is Quality of life?

Quality of life “…. Health is physical, mental and social well- being and not merely the absence of disease or infirmity...” –World Health Organization, 1947 Extending health to well-being: Quality of life What is the definition of quality of life?

Definitions of Quality of Life Quality of life is the degree of need and satisfaction within the physical, psychological, social, activity, material and structural area (Hörnquist, 1982). Quality of life is the subjective evaluation of good and satisfactory character of life as a whole (De Haes, 1988). Health related quality of life is the subjective experiences or preferences expressed by an individual, or members of a particular group of persons, in relation to specified aspects of health status that are meaningful, in definable ways, for that individual or group (Till, 1992). Quality of life is a state of well-being which is a composite of two components: 1) the ability to perform everyday activities which reflects physical psychological, and social well-being and 2) patient satisfaction with levels of functioning and the control of disease and/or treatment related symptoms (Gotay et al., 1992). An individual’s perception of their position in life in the context of the culture and values systems in which they live and in relation to their goals, expectations, standards and concerns (WHO Quality of life Groups, 1993).

No clear definition because: Many possible definitions –Multi-dimensionally –Subjective –Related to society Researchers are free to choose –The notion of measuring the quality of life could include the measurement of practically anything of interest to anybody. And, no doubt, everybody could find arguments supporting the selection of whichever set of indicators to be his choice (Andrews & Withy, 1976, page 6)

8 No clear definition because: Different origins of research –Clinical decision making: Does the patient benefit from the treatment? –Epidemiology (public health): what is the morbidity of the population? –Health economics: Is it worth the money?

Common items in definitions: Quality of life is subjective…. –“Given its inherently subjective nature, consensus was quickly reached that quality of life ratings should, whenever possible, be elicited directly from patients themselves. “ (Aaronson, in B Spilker (Ed): Quality of life and Pharmacoeconomics in Clinical Trails, 1996, page 180)

Common items in definitions: Health related Multidimensional –Physical, psychological, social Questionnaires –Standardize questions and response »Reproducible results: sciences »Quantify subjectivity Operational defined –Like IQ and temperature.

How to measure quality of life form a clinical point of view? Choose items –Are you able to walk one kilometer ? –Do you feel depressed ? Choose response mode –Binary yes / no –Multiple (Likert) yes / at bid / hardly / no –Continuous ( Visual Analogue Scale ) Always ————X—— Never Combine items to dimensions of quality of life –Sum up the items belonging to one dimension –Rescale sum on a scale from 0 to 100

12 Quality of life form a clinical point of view: profiles

13 Can profiles help? (1) SymptomsDrug XDrug Y Survival days Days sick of chemotherapy Days sick of disease TWiST

14 Can profiles help? (2) TWiST –Healthy = 1 –Sick (dead) = 0 There is more to life than sick/health –Make intermediate values –Q-TWiST »Quality of life adjusted adjusted TWiST How to scale quality of life? What is Quality of life?

15 How to scale QoL for Q-TWiST? One needs a uni-dimensional value of QoL –Like the IQ-test measures intelligence –Rules out multi-dimensional questionnaires Ratio or interval scale –Difference between 0 and.8 must be 8 time higher than.1 Four popular methods have these pretensions –Visual Analog Scale, Time Trade-Off, Standard Gamble, Person trade-off Plus validated questionnaires –HUI, EuroQol EQ-5D, 15-D, AQoL, etc

16 Value a health state You are in a wheelchair No pain or discomfort No psychosocial problems

17 Visual Analogue Scale VAS –Also called category scaling From psychological research “How is your quality of life today ?” “X” marks the spot –Response in centimeters –Rescale to [0..1] Dead Normal health X

18 Time Trade-Off TTO –Values Quality of Life in QALYs –Quality adjusted life years Wheelchair –With a life expectancy: 50 years How many years would you trade-off for a cure? –Max. trade-off is 10 years QALY(wheel) = QALY(healthy) –Y * V(wheel) = Y * V(healthy) –50 V(wheel) = 40 * 1 V(wheel) =.8

19 Q-TWiST = QALY When health (QoL) is valued in years –instead of of days…. Q-TWiST = Quality Adjusted Life Years –QALYs Q-TWiST invention of physicians QALY invention of economists

20 Patient values include coping Stensman –Scan J Rehab Med 1985;17: Scores on a visual analogue scale –36 subjects in a wheelchair –36 normal matched controls Mean score –Wheelchair: 8.0 –Health controls: 8.3 The patient perspective does not work in Health economics Healthy Death

21 The general public should be informed… Valuing without knowledge makes no sense –Thyroid Eye Disease Give description of the disease A patient with bilateral thyroid eye disease with upper lid retraction and exophthalmos.

22 Which health care program is the most cost-effective? A new wheelchair for elderly –Increases quality of life = 0.1 –10 years benefit –Extra costs: $ 3,000 per life year –QALY = Y x V(Q) = 10 x 0.1 = 1 QALY –Costs are 10 x $3,000 = $30,000 –Cost/QALY = 30,000/QALY Special post natal care –Quality of life = 0.8 –35 year –Costs are $250,000 –QALY = 35 x 0.8 = 28 QALY –Cost/QALY = 8,929/QALY

23 QALY league table

24 Implications shifting threshold QALY are weighted Weighted QALYs are maximized –Health is no longer the only thing maximized Health status population will drop Differences in health will drop –Egalitarian consideration are incorporated Burden of disease becomes a criteria

25 Shifting threshold

26 Practice

27 CE-ratio by equity

28 Conclusions Quality of life can be valued in –Profiles »Psychometric approach –Unidimensional scaling »Health economics Different perspective –Societal –Patient »Coping Quality of life definition –Operational defined Quality of life can moderate cost-effectiveness